Using TransR to enhance drug repurposing knowledge graph for COVID-19 and its complications
Methods · 2024
DOI: 10.1016/j.ymeth.2023.12.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods, 2024. Verfasst von Hongxi Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Computer and Control Engineering, Northeast Forestry University, 150040, Harbin, HeiLongJiang, China. Hauptthemen laut MEDLINE: Drug Repositioning, COVID-19. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
MOTIVATION: The COVID-19 pandemic has been spreading globally for four years, yet specific drugs that effectively suppress the virus remain elusive. Furthermore, the emergence of complications associated with COVID-19 presents significant challenges, making the development of therapeutics for COVID-19 and its complications an urgent task. However, traditional drug development processes are time-consuming. Drug repurposing, which involves identifying new therapeutic applications for existing drugs, presents a viable alternative. RESULT: In this study, we construct a knowledge graph by retrieving information on genes, drugs, and diseases from databases such as DRUGBANK and GNBR. Next, we employ the TransR knowledge representation learning approach to embed entities and relationships into the knowledge graph. Subsequently, we train the knowledge graph using a graph neural network model based on TransR scoring. This trained knowledge graph is then utilized to predict drugs for the treatment of COVID-19 and its complications. Based on experimental results, we have identified 15 drugs out of the top 30 with the highest success rates associated with treating COVID-19 and its complications. Notably, out of these 15 drugs, 10 specifically aimed at treating COVID-19, such as Torcetrapib and Tocopherol, has not been previously identified in the knowledge graph. This finding highlights the potential of our model in aiding healthcare professionals in drug development and research related to this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Computer and Control Engineering, Northeast Forestry University, 150040, Harbin, HeiLongJiang, China.
- College of Computer and Control Engineering, Northeast Forestry University, 150040, Harbin, HeiLongJiang, China; College of Life Science, Northeast Forestry University, 150040, Harbin, HeiLongJiang, China.
- School of Medicine and Health, Harbin Institute of Technology, 150001, Harbin, HeiLongJiang, China; Zhengzhou Research Institute, Harbin Institute of Technology, 450000, Zhengzhou, Henan, China.
- College of Computer and Control Engineering, Northeast Forestry University, 150040, Harbin, HeiLongJiang, China. Electronic address: yli@nefu.edu.cn.
- College of Computer and Control Engineering, Northeast Forestry University, 150040, Harbin, HeiLongJiang, China; College of Life Science, Northeast Forestry University, 150040, Harbin, HeiLongJiang, China. Electronic ad…
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Zhao, H., Li, H., Liu, Q., Dong, G., Hou, C., Li, Y., & Zhao, Y. (2024). Using TransR to enhance drug repurposing knowledge graph for COVID-19 and its complications. Methods. https://doi.org/10.1016/j.ymeth.2023.12.001
Vancouver
Zhao H, Li H, Liu Q, Dong G, Hou C, Li Y, et al. Using TransR to enhance drug repurposing knowledge graph for COVID-19 and its complications. Methods. 2024. doi:10.1016/j.ymeth.2023.12.001
BibTeX
@article{Zhao2024,
author = {Zhao, Hongxi and Li, Hongfei and Liu, Qiaoming and Dong, Guanghui and Hou, Chang and Li, Yang and Zhao, Yuming},
title = {Using TransR to enhance drug repurposing knowledge graph for COVID-19 and its complications},
journal = {Methods},
year = {2024},
doi = {10.1016/j.ymeth.2023.12.001}
}
EUVIMED